FDA Inspection
Conopco Inc. d/b/a UnileverConopco Inc. d/b/a Unilever – FDA Inspection, Sep 16, 2016
Record Details
This FDA Inspection record concerns Conopco Inc. d/b/a Unilever, with an inspection on September 16, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Conopco Inc. d/b/a Unilever
- Inspection Date
- September 16, 2016
- Product Type
- Drugs
View Company Profile
ID · f498f0da-bbcb-4fb3-a791-1fb87adc13ee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 989403
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Conopco Inc. d/b/a Unilever
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 13, 2026 | Not classified | Atlanta District Office | Drug Quality Assurance |
| May 27, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Conopco Inc. d/b/a Unilever
- FDA Inspection 1326098 - 2026-07-13
- FDA Inspection 1172861 - 2022-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.